Senior Director Patient Professional Advocacy

How will your role help us transform hope into reality

The Senior Director of Patient and Professional Advocacy will lead a unified strategy to connect patient advocacy and professional engagement for systemic mastocytosis (SM) and related mast cell diseases with a strong focus on driving impactful initiatives to support the SM launch within the United States (U.S.. This role will cultivate strong relationships with key patient organizations professional stakeholders and institutions to advance awareness advocacy and patient care for these rare conditions.

This leader will ensure patient insights are integrated into organizational strategies across R&D Medical Affairs U.S. Commercial Corporate Affairs and other functions with a particular emphasis on supporting SMrelated initiatives.

This position serves as a key advocacy liaison with professional societies fostering collaboration between advocates and healthcare providers to raise awareness encourage meaningful dialogue and deliver innovative solutions that enhance patient care. The Senior Director will design and execute strategic engagement initiatives across therapeutic areas ensuring alignment throughout the medicine development lifecycle with a special focus on launch readiness and patientcentered outcomes for SM.

You will work as a collaborative member of the crossfunctional team to bring the patient experience and perspective into development trial planning & recruitment and product launch. In partnership with the Patient Affairs Team you will engage directly with the patient community to ensure their voices shape key decisions meet critical education and advocacy needs and enhance access to vital information for those affected by cancer and mast cell diseases.

Additionally this role will integrate the insights and contributions of opinion leaders patient advocacy groups and professional societies into evidence generation global advisory efforts and strategic initiatives across medical affairs functions.

What will you do

Strategic Leadership and Planning

• Design and implement a strategy to integrate patient advocacy and professional engagement for systemic mastocytosis (SM) and related mast cell diseases building partnerships with professional societies healthcare providers and key advocates to drive shared initiatives in disease awareness education and patient support with a specific emphasis on supporting nonpromotional SM launch efforts by prioritizing disease education patient advocacy and professional engagement.
• Develop and lead a crossfunctional annual plan to gather unfiltered patient insights through advisory boards and other research efforts with patients advocates and influencers.
• Drive the amplification of the voice of patients influencing crossfunctional teams to bring forward the patient voice in a tangible way aligned with our core value of patient first.
• Develop metrics to measure the success of advocacy initiatives ensuring alignment with organizational goals.
• Manage budgets and resources for advocacyrelated programs to maximize efficiency and community impact.
• Stay informed of emerging trends and opportunities in advocacy adapting strategies to meet evolving needs.
• Ability to travel up to 30 including domestic and international travel.

PatientCentered Advocacy and Insights

• Integrate the patient voice across all stages of drug development and launch planning to ensure therapies address realworld needs with a key focus on SM.
• Partner with clinical research teams to ensure patient priorities are reflected in the development of meaningful clinical endpoints and outcomes leveraging insights from patient advocacy groups advisory boards and realworld experiences to shape trial design and evidence generation.
• Act as a patient advocacy representative to ensure patient perspectives and needs are integrated into research development and strategic planning efforts.
• Integrate patient insights into development and commercialization efforts by recommending actionable evidencebased strategies across teams and executing initiatives within the advocacy function to drive patientcentered decisionmaking advance disease education and enhance advocacy outcomes.
• Collaborate with Health Economics and Outcomes Research (HEOR) teams to integrate patient insights into evidence generation and strategic initiatives ensuring SMfocused outcomes are prioritized.

Professional Advocacy and Collaboration

• Create and execute a comprehensive engagement strategy with healthcare providers (HCPs) professional societies and institutions to advance patient advocacy within their communities.
• Build partnerships that drive collaborative advocacy efforts such as APSHO initiatives on disease control and patientcentered care.
• Work closely with Medical Affairs to align on strategic priorities and support joint advocacy efforts.

Community Engagement and Representation

• Design and implement initiatives that align patient and professional communities throughout the medicine development lifecycle including clinical trial planning recruitment product launches and educational programs.
• Represent the organization at advocacy forums professional conferences and community events to drive visibility and engagement.
• Perform other responsibilities as assigned

What minimum qualifications do we require

• Bachelors Degree in public health nursing life sciences communications or a related field
• 10 years of experience in patient advocacy or equivalent experience in the pharmaceutical/biotech sector

What additional qualifications will make you a stronger candidate

• Demonstrated success in navigating regulatory and legal compliance related to advocacy efforts.
• Deep understanding of commercialization and R&D including experience with commercial product launches.
• Proven Leadership in CrossFunctional Teams
• Experience in allergy/immunology other rare disease or oncology experience.
• Excellent communication collaboration and leadership skills to effectively engage crossfunctional teams patients and external stakeholders.
• Agile strategic leader adept at navigating fastpaced environments shifting priorities and ambiguity to drive patientcentered impact and measurable outcomes.
• Commitment to our Core Values: Patients First Thoughtfulness Urgency Trust Optimism

Why Blueprint

At Blueprint Medicines we achieve impactful results because of our global crew of compassionate innovators the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights which drives our success.

This is the place where the extraordinary becomes reality and you could be part of it.

Patients are waiting. Are you ready to make the leap

Equity Diversity Inclusion and Affirmative Action

At Blueprint Medicines we foster a culture of equity diversity and inclusion. A proud Equal Employment Opportunity and Affirmative Action employer we consider all qualified applicants without regard to race color sex gender identity or expression sexual orientation age religion national origin ancestry ethnicity disability veteran status genetic information or any other characteristic protected under applicable law. We are also an EVerify Employer. We will make reasonable accommodations absent undue hardship for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process please reach out to

For more information please see ourEEOAA Policy Statement the EVerify Participation Poster the Right to Work Poster and/or theEEO Know Your Rights Poster as well as ourPay Transparency Statement.

Blueprint Medicines is a global fully integrated biopharmaceutical company that invents lifechanging medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines including bringing our medicine to patients with systemic mastocytosis (SM) in the U.S. and Europe. Leveraging our established research development and commercial capability and infrastructure we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including SM and chronic urticaria breast cancer and other solid tumors.

#LIHybrid